DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Acular (Ketorolac Tromethamine Ophthalmic) - News

 
 



News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for

UF Health research points to potential treatment for macular degeneration, uveitis
Source: Eye Health / Blindness News From Medical News Today [2015.02.25]
Inflammation is a major culprit in age-related macular degeneration and some other eye diseases.

Comparative effectiveness trial in diabetic macular edema published
Source: Diabetes News From Medical News Today [2015.02.24]
Regeneron Pharmaceuticals, Inc. has announced that results from the National Institutes of Health (NIH)-sponsored, Diabetic Retinopathy Clinical Research Network comparative effectiveness study in...

UW ophthalmologists help demonstrate effectiveness of diabetic macular edema treatments
Source: Diabetes News From Medical News Today [2015.02.24]
An ophthalmology research team at the University of Wisconsin-Madison took part in a nationwide clinical trial comparing treatments for a form of diabetic eye disease.

Johns Hopkins helps lead discovery on efficacy and safety of 3 drugs for treating diabetic macular edema
Source: Diabetes News From Medical News Today [2015.02.24]
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three...

Joslin researchers find drugs are effective for diabetic macular edema in new trial
Source: Diabetes News From Medical News Today [2015.02.23]
In the first clinical trial directly comparing three drugs most commonly used to treat diabetic macular edema, researchers found all were effective in improving vision and preventing vision loss.

NICE gives EYLEA a provisional green light to treat patients with visual impairment due to diabetic macular oedema
Source: Eye Health / Blindness News From Medical News Today [2015.02.23]
Bayer HealthCare is pleased that NICE has recognised the benefits of EYLEA (aflibercept solution for injection) for the treatment of visual impairment due to diabetic macular oedema (DMO) according...

Macular Degeneration
Source: MedicineNet Visual Field Test Specialty [2014.01.23]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 6:05:00 PM
Last Editorial Review: 1/23/2014 12:00:00 AM

Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.

'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010

Best drug to improve poor vision in diabetes
Source: Diabetes News From Medical News Today [2015.02.22]
Study will help doctors and patients choose best treatment Eylea is most effective for improving the eyesight of patients with poor vision Diabetic macular edema is major cause of...

Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015